Amneal Pharmaceuticals

AMRX · NASDAQ

$19.84+$0.48 (+2.48%)TodayMarket closed ·
Prev close $19.36

Who owns AMRX

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 26.3% of AMRX’s shares.

  • Fosun International Ltd6.7%
  • Patel (Gautam)4.2%
  • The Vanguard Group, Inc.4.1%
  • TPG Capital, L.P.3.9%
  • Next 6 largest institutions7.4%
  • All other shareholders73.7%
Top institutional holders of AMRX
HolderShares% of shares
Fosun International Ltd21.52M6.74%
Patel (Gautam)13.26M4.15%
The Vanguard Group, Inc.13.01M4.08%
TPG Capital, L.P.12.33M3.86%
BlackRock Institutional Trust Company, N.A.7.22M2.26%
Eversept Partners, LP5.27M1.65%
Neuberger Berman, LLC3.75M1.17%
Norges Bank Investment Management (NBIM)2.71M0.85%
Rubric Capital Management LP2.60M0.81%
State Street Global Advisors (US)2.23M0.70%

Largest mutual fund holders

Top mutual fund holders of AMRX
HolderShares% of shares
Vanguard Total Stock Market Index Fund4.06M1.27%
Vanguard Small-Cap Index Fund3.57M1.12%
iShares Russell 2000 ETF2.83M0.89%
Statens Pensjonsfond Utland2.71M0.85%
Vanguard Small-Cap Value Index Fund2.50M0.78%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders sold $7.67M (5 trades) of AMRX on the open market, with no buys.

Latest AMRX insider transactions
InsiderTypeSharesValue
BUCHI J KEVINGift20.45K—
BUCHI J KEVINOption exercise20.45K—
BUCHI J KEVINOption exercise20.45K$295.43K
BOYER ANDREW SGift80.00K—
BOYER ANDREW SGift152.43K—
Kiely JohnGift10.00K—
Kiely JohnSale50.00K$882.00K
Shah NikitaSale146.40K$2.56M
Daly Jason B.Sale210.00K$3.65M
Daly Jason B.Sale6.61K$117.05K

Short interest

Settled Sep 30, 2026

Shares short
11.28M
Days to cover
3.06
% of shares outstanding
3.53%
Average daily volume
3.69M
Change since last report
−0.1%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.